Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

ARHS February 26, 2026

Arhaus Fourth Quarter and Full Year 2025 Earnings Call - Record Net Revenue, Reinvestment and Tariff Headwinds

Arhaus closed 2025 with record net revenue of $1.38 billion, but the headline growth belies a transitional year. Management is explicitly in a reinvestment phase: showroom expansion, a multiyear digit...

  • Record 2025 net revenue of $1.38 billion, up 8.5% year over year, marking continued scale since 2019 when the business was much smaller.
  • Adjusted EBITDA rose 8.9% to $145 million for 2025, with adjusted EBITDA margin flat at 10.5%, showing operating resilience amid reinvestment.
  • Gross margin for the year was 38.9%, down 50 basis points, and Q4 gross margin fell to 38.1%, down 190 basis points driven largely by a $? inventory reserve and higher showroom occupancy costs.
  • +12 more takeaways
AMBP February 26, 2026

Ardagh Metal Packaging S.A. Q4 2025 Earnings Call - EBITDA beat, $1.3bn green bond refi, but metal supply pain may linger into H1 2026

Ardagh Metal Packaging closed 2025 with a clear beat and a puzzle. Full-year Adjusted EBITDA came in at $739 million, up 10% year over year, and Q4 Adjusted EBITDA of $166 million topped guidance. The...

  • Full-year 2025 Adjusted EBITDA was $739 million, a 10% increase versus 2024 and well above initial guidance of $675m-$695m.
  • Q4 2025 Adjusted EBITDA was $166 million, exceeding the guidance range of $147m-$162m.
  • AMP raised $1.3 billion of green bonds in December, using proceeds to repay $600m of 2027 notes, a EUR 269m term loan, and redeem EUR 250m of preferred shares.
  • +14 more takeaways
GMRE February 26, 2026

Chiron Real Estate Q4 2025 Earnings Call - Pivot into senior housing while fortifying balance sheet

Chiron used its inaugural earnings call to lay out a clear strategic pivot: protect the balance sheet, squeeze more yield from its medical office base, and aggressively expand into senior housing and ...

  • Chiron presented its first formal strategy as a rebranded company, emphasizing the mission of delivering value at the intersection of care, capital, and real estate.
  • Management expects a new interest-rate normal, mentioning 4% 10-year Treasuries and anticipating 2%–3% rent growth for medical office, prompting a playbook rewrite that prioritizes earnings growth.
  • Alex Wilburn was named Portfolio Manager to lead a more market-oriented, active asset-management approach across the existing medical office portfolio.
  • +14 more takeaways
INSW February 26, 2026

International Seaways Inc. Q4 2025 Earnings Call - $2.15 Dividend Signals Confidence in Tanker Upcycle and Strong Balance Sheet

International Seaways closed 2025 with a hefty quarter and an even heftier statement of intent. Q4 net income was $128 million ($2.56 diluted), adjusted net was $122 million ($2.45) and adjusted EBITD...

  • Q4 2025 net income was $128 million, or $2.56 per diluted share; adjusted net income was $122 million, or $2.45; adjusted EBITDA was $175 million.
  • Company declared largest ever quarterly dividend, $2.15 per share to be paid in March, equal to an 87% payout of Q4 adjusted net income; cumulative returns to shareholders since 2020 exceed $1 billion.
  • Seaways runs a $50 million share repurchase program through end-2026 as an add-on to dividend policy, but management prioritized dividends over additional deleveraging.
  • +12 more takeaways
BSY February 26, 2026

Bentley Systems Q4 2025 Earnings Call - Asset analytics and API-driven digital twins are the near-term revenue story, AI in design is a longer game

Bentley closed 2025 with steady, durable top-line and cash generation, and handed investors a confident 2026 roadmap built on low-double-digit ARR growth, margin expansion, and heavy emphasis on AI-en...

  • Q4 ARR ended at $1.462 billion, growing 11.5% year-over-year on a constant currency basis, with sequential AR growth of 4% in Q4.
  • Total 2025 revenue was $1.502 billion, up 11% reported (10% constant currency); Q4 revenue was $392 million, up 12% reported (10% constant currency).
  • Subscription revenues now represent 92% of total revenues and grew ~13% for the year; E365 accounts for 45% of subscription revenue (up from 42%).
  • +17 more takeaways
WWW February 26, 2026

Wolverine World Wide Fourth Quarter Fiscal 2025 Earnings Call - Saucony-fueled growth offsets tariff-driven margin pressure

Wolverine closed fiscal 2025 with healthy top-line momentum led by Saucony and Merrell, improving gross margins and a much stronger balance sheet. Management is bullish on brand-driven DTC recovery an...

  • Fiscal 2025 revenue $1.874 billion, up 7% reported and 6% constant currency; full year adjusted EPS $1.35, up 53% vs. 2024.
  • Q4 revenue $517 million, above guidance midpoint; Q4 reported growth 5%, constant currency up 3% (foreign exchange +$8M).
  • Saucony was the standout brand, posting a record year and +24% revenue in Q4, with DTC up mid-teens and management guiding Saucony to low- to mid-teens growth in 2026.
  • +13 more takeaways
WVE February 26, 2026

Wave Life Sciences Q4 2025 Earnings Call - WVE-007 shows semaglutide-like fat loss with muscle preservation, supporting once- or twice-year dosing

Wave pushed two clear narratives: WVE-007 is translating compelling preclinical INHBE biology into human signals of fat loss with muscle preservation, and its RNA editing programs, led by WVE-006 for ...

  • INLIGHT single-dose 240 mg cohort: placebo-adjusted 4% reduction in total fat, 9.2% reduction in visceral fat, and a 0.9% increase in lean mass at 3 months, in a Phase 1 cohort with average BMI ~32 and no diet/exercise interventions.
  • Management claims durable Activin E suppression supporting potential once- or twice-year dosing, with a clean safety profile reported through the 600 mg cohort.
  • Phase IIa multi-dose (MAD) portion of INLIGHT, enrolling higher BMI patients with comorbidities and MRI/MRI-PDFF endpoints for body composition and liver fat, is on track to start in H1 2026.
  • +11 more takeaways
RY February 26, 2026

RBC Q1 2026 Earnings Call - Record revenue and 17.6% ROE as capital markets, wealth and banking drive growth

RBC reported a blowout Q1 2026: record revenue of nearly CAD 18 billion and adjusted earnings of CAD 5.9 billion powered pre-provision, pre-tax income to about CAD 8.5 billion, driving a 17.6% return ...

  • RBC posted record revenue of nearly CAD 18 billion and adjusted earnings of CAD 5.9 billion for Q1 2026, with pre-provision, pre-tax earnings of approximately CAD 8.5 billion, up 14% year-over-year.
  • Return on equity hit 17.6% this quarter, supported by a Common Equity Tier 1 ratio of 13.7%, giving management room for buybacks and deployment.
  • Share buybacks totaled roughly 4.2 million shares for about CAD 1 billion in the quarter; dividend policy remains progressive and tied to sustainable earnings growth within a 40%–50% payout objective.
  • +12 more takeaways
CAPL February 26, 2026

CrossAmerica Partners Q4 2025 Earnings Call - Strong fuel margins and record asset sales trimmed leverage and boosted cash flow

CrossAmerica finished 2025 on firmer footing, driven by a sharp improvement in fuel margins and the largest year of asset sales in company history. Q4 adjusted EBITDA rose 22% year over year to $43.4 ...

  • Q4 adjusted EBITDA rose 22% year over year to $43.4 million, while Q4 net income was $10.2 million versus $16.9 million a year ago, driven by fewer gains on asset dispositions.
  • Distributable Cash Flow for Q4 was $28.5 million, up 35% year over year; distribution coverage in the quarter improved to 1.43x from 1.06x a year earlier.
  • Retail segment gross profit in Q4 increased 10% to $82.9 million, helped by a 19% increase in retail fuel margin to 44.9 cents per gallon.
  • +11 more takeaways
EE February 26, 2026

Excelerate Energy Q4 and Full Year 2025 Earnings Call - 2026 EBITDA Guidance Raised as Iraq FSRU Nears Delivery and Jamaica Integration Completes

Excelerate closed 2025 with record adjusted EBITDA of $449 million, driven by the May 2025 Jamaica acquisition, robust operational reliability above 99.9%, and reduced operating costs. Management is g...

  • Record full-year 2025 adjusted EBITDA of $449 million, about $100 million above prior year, driven largely by the Jamaica acquisition and higher LNG gas and power activity.
  • Full-year 2026 adjusted EBITDA guidance of $515 million to $545 million, midpoint represents roughly an $80 million increase versus 2025, grounded in operating assets and near-term projects.
  • Hull 3407, a new best-in-class FSRU, completed sea trials and is progressing through commissioning, with delivery expected in early Q2 2026.
  • +12 more takeaways